Milan Piroš

Dr. Milan Piroš


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2023 in Inorganics
Verified
Journal Article
Open access
PDF file
MPMilan Piroš
Milan Piroš
MSMartin Schoeller
Martin Schoeller
KKKatarína Koňariková
Katarína Koňariková
JVJindra Valentova
Jindra Valentova
Ľubomír ŠvorcĽubomír Švorc
Ľubomír Švorc
JŠJozef Švorec
Jozef Švorec
Herein, we discuss the synthesis, structural and spectroscopic characterization, and biological activity of five heteroligand copper(II) complexes with diethylnicotinamide and various fenamates, as follows: flufenamate (fluf), niflumate (nifl), tolfenamate (tolf), clonixinate (clon), mefenamate (mef) and N, N-diethylnicotinamide (dena). The complexes of composition: [Cu(fluf)2(dena)2(H2O)2] (1), [Cu(nifl)2(dena)2] (2), [Cu(tolf)2(dena)2(H2O)2] (3), [Cu(clon)2(dena)2] (4) and [Cu(mef)2(dena)2(H2O)2] (5), were synthesized, structurally (single-crystal X-ray diffraction) and spectroscopically characterized (IR, EA, UV-Vis and EPR). The studied complexes are monomeric, forming a distorted tetragonal bipyramidal stereochemistry around the central copper ion. The crystal structures of all five complexes were determined and refined with an aspheric model using the Hirshfeld atom refinement method. Hirshfeld surface analysis and fingerprint plots were used to investigate the intermolecular interactions in the crystalline state. The redox properties of the complexes were studied and evaluated via cyclic voltammetry. The complexes exhibited good superoxide scavenging activity as determined by an NBT assay along with a copper-based redox-cycling mechanism, resulting in the formation of ROS, which, in turn, predisposed the studied complexes for their anticancer activity. The ability of complexes 1–4 to interact with calf thymus DNA was investigated using absorption titrations, viscosity measurements and an ethidium-bromide-displacement-fluorescence-based method, suggesting mainly the intercalative binding of the complexes to DNA. The affinity of complexes 1–4 for bovine serum albumin was determined via fluorescence emission spectroscopy and was quantitatively characterized with the corresponding binding constants. The cytotoxic properties of complexes 1–4 were studied using the cancer cell lines A549, MCF-7 and U-118MG, as well as healthy MRC-5 cells. Complex 4 exhibited moderate anticancer activity on the MCF-7 cancer cells with IC50 = 57 μM.

7 June 2023 in Molecules
Verified
Journal Article
Open access
PDF file
MSMartin Schoeller
Martin Schoeller
MPMilan Piroš
Milan Piroš
MLMiroslava Litecka
Miroslava Litecka
KKKatarína Koňariková
Katarína Koňariková
FJFlóra Jozefíková
Flóra Jozefíková
JMJan Moncol
Jan Moncol
Ruthenium complexes currently represent a perspective subject of investigation in terms of potential anticancer therapeutics. Eight novel octahedral ruthenium(II) complexes are the subject of this article. Complexes contain 2,2′-bipyridine molecules and salicylates as ligands, differing in position and type of halogen substituent. The structure of the complexes was determined via X-ray structural analysis and NMR spectroscopy. All complexes were characterized by spectral methods—FTIR, UV–Vis, ESI-MS. Complexes show sufficient stability in solutions. Therefore, their biological properties were studied. Binding ability to BSA, interaction with DNA, as well as in vitro antiproliferative effects against MCF-7 and U-118MG cell lines were investigated. Several complexes showed anticancer effects against these cell lines.

27 April 2023 in Inorganics
Verified
Journal Article
Open access
PDF file
MSMartin Schoeller
Martin Schoeller
MPMilan Piroš
Milan Piroš
KLKarol Lušpai
Karol Lušpai
JBJana Braniša
Jana Braniša
JMJan Moncol
Jan Moncol
A new polymorph of the ruthenium(II) diclofenac complex with formula [Ru(p-cymene)(diclo)Cl] was synthesized, and its crystal structure was solved by single crystal X-ray diffraction. The structure was refined by HAR, using five different relativistic bases sets (x2c-SVP, jorge-DZP-DKH, jorge-TZP-DKH, x2c-TZVP, and x2c-TZVPP) and three effective core potential basis sets (ECP-def2-SVP, ECP-def2-TZVP, and ECP-def2-TZVPP). Their influence on the structure parameters was compared. The analysis of the supramolecular structure of the HAR/non-HAR structures, as well as of the orthorhombic polymorph, was supported by the calculation and analysis of the Hirshfeld surfaces. The best results were observed for HAR using triple-zeta-based sets. No significant effect of base choice on Hirshfeld surfaces was observed. A study of the ability of the complex to interact with ct-DNA was also performed. The complex was shown to interact with ct-DNA, but the mode of interaction is not fully elucidated.